Related by context. All words. (Click for frequent words.) 84 gemcitabine 79 trastuzumab 79 carboplatin 79 Taxotere 77 paclitaxel 77 rituximab 77 bevacizumab 76 cisplatin 76 capecitabine 76 cetuximab 76 pemetrexed 76 erlotinib 76 irinotecan 75 carboplatin paclitaxel 74 bortezomib 74 temozolomide 74 oxaliplatin 74 docetaxel chemotherapy 74 FOLFOX 74 5 FU 74 monotherapy 73 topotecan 73 dacarbazine 73 imatinib 73 Taxotere ® 73 sunitinib 72 cytarabine 72 fluorouracil 71 lapatinib 71 FOLFIRI 71 chlorambucil 71 gefitinib 71 sorafenib 71 pegylated liposomal doxorubicin 71 Fludara 71 taxane 71 5 fluorouracil 71 doxorubicin 71 pegylated interferon 71 mitoxantrone 70 vinorelbine 70 leucovorin 70 5FU 69 zoledronic acid 69 metastatic colorectal cancer 69 goserelin 69 HER2 positive metastatic breast 69 chemoradiotherapy 69 5-FU/LV 69 nab paclitaxel 69 Taxotere R 69 gemcitabine chemotherapy 69 decitabine 69 FOLFOX4 69 bevacizumab Avastin 69 advanced NSCLC 69 plus ribavirin 69 metastatic renal cell carcinoma 69 dasatinib 69 interferon alfa 69 docetaxel Taxotere 69 cyclophosphamide 69 neoadjuvant chemotherapy 68 sorafenib Nexavar 68 temsirolimus 68 azacitidine 68 paclitaxel chemotherapy 68 fludarabine 68 epirubicin 68 chemotherapy regimens 68 plus dexamethasone 68 daunorubicin 68 low dose cytarabine 68 vandetanib 68 Gemcitabine 68 standard chemotherapy regimen 67 paclitaxel carboplatin 67 lamivudine 67 hormone refractory prostate cancer 67 mapatumumab 67 peginterferon alfa 2a 67 etoposide 67 Tarceva 67 peginterferon 67 chemoradiation 67 etanercept 67 panitumumab 67 pertuzumab 67 bendamustine 67 interferon alfa 2a 67 trabectedin 67 Xeloda 67 peg IFN 67 Peg IFN 67 dexamethasone 67 chemotherapy regimen 67 ribavirin 66 paclitaxel Taxol 66 adjuvant therapy 66 free survival PFS 66 lenalidomide 66 infusional 5-FU/LV 66 methotrexate 66 interferon alpha 66 Vectibix 66 metastatic breast cancer 66 Doxil ® 66 azathioprine 66 Irinotecan 66 ixabepilone 66 fluoropyrimidine 66 mycophenolate mofetil 66 estramustine 66 mRCC 66 peginterferon alfa 2b 66 gemcitabine cisplatin 66 pegylated interferon alpha 66 metastatic hormone refractory 66 Doxil 66 XELOX 66 relapsed ovarian cancer 66 idarubicin 66 T DM1 66 CANCIDAS 66 pegylated interferon alfa 2a 65 clodronate 65 plus prednisone 65 plus gemcitabine 65 pomalidomide 65 platinum refractory 65 anti TNF 65 sorafenib Nexavar ® 65 glufosfamide 65 dose cytarabine 65 HRPC 65 adalimumab 65 Folfox 65 mcg kg 65 docetaxel Taxotere ® 65 Pegasys ® 65 Femara 65 recurrent GBM 65 Abraxane 65 VIDAZA 65 DMARDs 65 letrozole 65 erlotinib Tarceva ® 65 adriamycin 65 NSCLC 65 interferon 65 Docetaxel 65 DMARD 65 cetuximab Erbitux ® 65 active comparator 65 lopinavir r 64 Capecitabine 64 bevacizumab Avastin ® 64 TACE 64 APTIVUS r 64 ribavirin RBV 64 tamoxifen 64 median PFS 64 Hycamtin 64 docetaxel Taxotere R 64 Genasense 64 administered subcutaneously 64 axitinib 64 metformin 64 CoFactor 64 raltegravir 64 Herceptin trastuzumab 64 mitomycin 64 cisplatin chemotherapy 64 gemcitabine Gemzar 64 #mg/m# [001] 64 melphalan 64 nilotinib 64 eribulin 64 ritonavir boosted 64 picoplatin 64 BEACOPP 64 G CSF 64 gemcitabine carboplatin 64 Pegasys plus Copegus 64 Erlotinib 64 REBETOL 64 Cisplatin 64 dose dexamethasone 64 adjuvant chemotherapy 64 FOLFOX6 64 Ixempra 64 hormonal therapy 64 CHOP chemotherapy 64 pegylated interferon alfa 2b 64 anastrozole 64 Amrubicin 64 metastatic CRC 64 resistant ovarian cancer 64 chemotherapy docetaxel 64 ELOXATIN 64 mg/m2 64 Tarceva TM 63 heavily pretreated patients 63 DOXIL 63 oblimersen 63 YONDELIS 63 relapsed CLL 63 melphalan prednisone 63 refractory multiple myeloma 63 PegIFN RBV 63 chemotherapy cisplatin 63 neoadjuvant treatment 63 SCH # 63 LEXIVA r 63 Platinol 63 trastuzumab Herceptin R 63 TAXOTERE R 63 abiraterone 63 pegylated interferon alfa 63 Cytoxan 63 chemotherapy gemcitabine 63 Torisel 63 low dose dexamethasone 63 liposomal doxorubicin 63 valopicitabine 63 doxorubicin cyclophosphamide 63 cabazitaxel 63 nitazoxanide 63 Rituxan 63 imetelstat 63 Tarceva erlotinib 63 ABRAXANE 63 remission induction 63 Taxotere docetaxel 63 Targretin 63 darunavir ritonavir 63 TYKERB 63 tenofovir emtricitabine 63 Gemzar ® 63 Carboplatin 63 cytotoxic chemotherapy 63 Imprime PGG 63 Trastuzumab 63 PREZISTA r 63 neoadjuvant 63 TNF inhibitor 63 irbesartan 63 neoadjuvant therapy 63 chemotherapies 63 taxanes 63 Nexavar 63 dose cohorts 63 adefovir 63 telaprevir dosed 63 Vidaza 63 Alkeran 62 imatinib therapy 62 lapatinib Tykerb 62 EFAPROXYN 62 metastatic RCC 62 iniparib 62 CIMZIA TM 62 #mg/m# [002] 62 PegIntron 62 cyclophosphamide methotrexate 62 refractory AML 62 Tykerb 62 heavily pretreated 62 sunitinib malate 62 interferon alfa 2b 62 HGS ETR1 62 Bortezomib 62 Hycamtin ® 62 boosted protease inhibitor 62 mg dose 62 abiraterone acetate 62 infliximab 62 alkylating agent 62 adjuvant 62 doxorubicin HCl liposome injection 62 dexamethasone Decadron 62 tipranavir 62 FOLPI 62 pazopanib 62 VELCADE melphalan 62 Jevtana 62 FOLFIRI alone 62 ibandronate 62 entecavir 62 mg QD 62 irinotecan chemotherapy 62 chemotherapeutic agent 62 capecitabine Xeloda 62 FluCAM 62 mCRC 62 alfa 2a 62 fluconazole 62 Avastin 62 Halaven 62 insulin glargine 62 protease inhibitor PI 62 nelfinavir 62 comparator arm 62 tolerability 62 mg m 62 metastatic castration resistant 62 tamoxifen therapy 62 adecatumumab 62 anthracycline taxane 62 Platinol ® cisplatin 62 abacavir lamivudine 62 sapacitabine 62 Herceptin 62 protease inhibitor 62 aflibercept 62 Bevacizumab 62 perifosine 62 zalutumumab 62 HER2 positive 62 dacarbazine chemotherapy 62 ABC/3TC 62 postoperative chemotherapy 62 OncoVEX GM CSF 62 RG# [001] 62 virologic failure 62 VELCADE 61 taxane therapy 61 5 FU leucovorin 61 IMGN# 61 paclitaxel Taxol R 61 imatinib Gleevec 61 Taxol 61 subcutaneous SC 61 LPV r 61 NNRTI 61 docetaxel prednisone 61 NRTIs 61 peginterferon alfa 2a Pegasys 61 tesmilifene 61 tiotropium 61 ISENTRESS 61 3TC 61 Pemetrexed 61 INCB# [001] 61 evaluating tivozanib 61 celgosivir 61 idraparinux 61 tocilizumab 61 Navelbine 61 Gliadel Wafer 61 paclitaxel Taxol ® 61 Velcade bortezomib 61 bortezomib Velcade R 61 seliciclib 61 CA4P 61 oral clodronate 61 concurrent chemoradiation 61 mg m² 61 dasatinib Sprycel ® 61 PEGINTRON 61 MabCampath 61 IRESSA 61 vorinostat 61 octreotide 61 TORISEL 61 Dasatinib 61 evaluable patients 61 epirubicin cyclophosphamide 61 metastatic GIST 61 chemotherapeutic regimen 61 chemotherapeutic agents 61 ipilimumab 61 Allovectin 7 ® 61 OPAXIO 61 trastuzumab Herceptin ® 61 relapsed multiple myeloma 61 TMC# [001] 61 Xeloda ® 61 unresectable 61 progression TTP 61 Xcytrin 61 HGS# 61 taxane chemotherapy 61 achieved ACR# 61 superficial bladder cancer 61 mg kg dose 61 talabostat 61 HER2 negative 61 cetuximab Erbitux R 61 teriflunomide 61 Taxotere chemotherapy 61 Fludara ® 61 atazanavir 61 placebo 61 mCRC patients 61 peg interferon 61 μg dose 61 custirsen 61 mitoxantrone chemotherapy 61 afatinib 61 Panzem R NCD 61 placebo dexamethasone 61 dose escalation 61 ERBITUX 61 ceftriaxone 61 bicalutamide 61 octreotide LAR 61 standard chemotherapy regimens 61 preoperative chemotherapy 61 Xeloda capecitabine 61 mg qd 61 neratinib 61 thymalfasin 61 cilengitide 61 adalimumab Humira 61 relapsing multiple sclerosis 61 Elitek 61 letrozole Femara 60 recurrent NSCLC 60 gefitinib Iressa 60 vicriviroc 60 EBRT 60 satraplatin 60 biologic therapy 60 EGFR TKI 60 COPEGUS 60 Avastin bevacizumab 60 FOLOTYN 60 clopidogrel 60 enfuvirtide 60 sorafenib tablets 60 sitagliptin 60 trastuzumab Herceptin 60 Gefitinib 60 chemotherapy 60 elotuzumab 60 darunavir 60 Sandostatin LAR 60 intermittent dosing 60 gemcitabine Gemzar ® 60 cisplatin gemcitabine 60 antitumor activity 60 capecitabine Xeloda R 60 sipuleucel T 60 oral antidiabetic 60 arsenic trioxide 60 Bezielle 60 5 fluorouracil leucovorin 60 Aromasin 60 adjuvant tamoxifen 60 tyrosine kinase inhibitor 60 chronic lymphocytic leukemia CLL 60 aromatase inhibitor 60 YERVOY 60 exemestane 60 SCCHN 60 virologic response 60 intravenous bisphosphonates 60 Chemophase 60 RAD# [003] 60 Zevalin 60 Ribavirin 60 tenofovir Viread 60 Proxinium TM 60 chemotherapeutic regimens 60 mg kg 60 HuMax CD4 60 Sanofi Aventis Taxotere 60 degarelix 60 subcutaneously administered 60 Ceplene/IL-2 60 lopinavir ritonavir 60 dacetuzumab 60 elagolix 60 posaconazole 60 PXD# 60 dosing cohorts 60 anthracycline 60 Campath alemtuzumab 60 telaprevir 60 adjuvant radiation 60 tyrosine kinase inhibitors 60 5 Fluorouracil 60 eribulin mesylate 60 fosamprenavir 60 cyclophosphamide chemotherapy 60 paclitaxel poliglumex 60 amrubicin 60 dose regimens 60 chemotherapeutic drug 60 Clolar 60 ritonavir 60 calcitriol 60 rituximab Rituxan 60 Cloretazine 60 PREZISTA rtv 60 AVASTIN 60 ASA# 60 Omnitarg 60 Taxol ® 60 enzastaurin 60 dacarbazine DTIC 60 febuxostat 60 Camptosar 60 ACTEMRA TM 60 mcg albinterferon alfa 2b 60 CAELYX 60 Revlimid lenalidomide 60 APTIVUS 60 PegIFN 60 randomized Phase III 60 viral kinetics 60 dose escalation study 60 oral deforolimus 60 partial remissions 60 peginterferon alpha 2a 60 refractory NSCLC 60 TELCYTA 60 VAPRISOL 60 certolizumab 60 TNF inhibitors 60 INTELENCE 60 metastatic melanoma 60 TEMODAL 60 GnRH agonists 60 oral allopurinol 60 DAVANAT 60 cisplatin vinorelbine 60 baminercept 60 androgen independent 60 leuprorelin 60 lenalidomide Revlimid R 60 mg ustekinumab 60 MGd 60 oral rivaroxaban 60 fluticasone 60 Pegasys peginterferon alfa 2a 60 liver metastases 60 HER2 positive breast cancer 60 cobicistat 60 prostate cancer HRPC 60 ascending doses 60 luteinizing hormone releasing 60 amoxicillin clavulanate 60 XGEVA 60 pioglitazone 60 brain metastases 60 Traficet EN 60 Camptosar ® 59 levosimendan 59 forodesine 59 mg BID 59 dose escalation trial 59 GVAX 59 splenectomized patients 59 chemotherapy FOLFOX 59 phenoxodiol 59 Fludarabine 59 CRp 59 unfractionated heparin 59 8mg/kg 59 oral Xeloda 59 doxorubicin docetaxel 59 flutamide 59 Laquinimod 59 FOLFOX4 alone 59 dosing regimens 59 pamidronate 59 bone metastases 59 clofarabine 59 tanespimycin 59 phase IIb clinical 59 FOLFOX regimen 59 neurologic progression 59 Lenalidomide 59 rHuPH# 59 TRISENOX 59 fulvestrant 59 amphotericin B 59 DAPT 59 CR# vcMMAE 59 REYATAZ R 59 Velcade 59 Dacogen 59 epoetin alfa 59 locoregional 59 4mg/kg 59 alendronate 59 pegfilgrastim 59 saline placebo 59 AEGR 59 anti TNF alpha 59 Lapatinib 59 PEG Interferon lambda 59 dasatinib Sprycel 59 peginterferon alfa 59 Oxaliplatin 59 Hepsera 59 metastatic HRPC 59 refractory ovarian cancer 59 ritonavir boosted atazanavir 59 elacytarabine 59 gastrointestinal stromal tumor GIST 59 Sutent 59 refractory CLL 59 tipranavir r 59 injected subcutaneously 59 insulin detemir 59 administered orally 59 relapsed refractory 59 external beam radiotherapy 59 MIRCERA 59 galiximab 59 TTF Therapy 59 Rebetol 59 PROSTVAC ® 59 cetuximab Erbitux 59 interferon ribavirin 59 MGCD# [002] 59 diagnosed multiple myeloma 59 milatuzumab 59 Paclitaxel 59 Copegus ribavirin 59 GRN#L 59 relapsed SCLC 59 thalidomide Thalomid 59 castration resistant prostate cancer 59 Free Survival PFS 59 cediranib 59 recurrent ovarian cancer 59 assessing T DM1 59 piperacillin tazobactam 59 HGS ETR2 59 pCR 59 cell lymphoma CTCL 59 Gemzar 59 Gleevec 59 cytotoxic therapy 59 Pegylated Interferon 59 Erbitux 59 linezolid 59 bosutinib 59 allopurinol 59 ustekinumab 59 ELACYT 59 Taxol paclitaxel 59 Phase Ib clinical 59 bleomycin 59 ALIMTA 59 Xelox 59 bortezomib Velcade 59 tamsulosin 59 carvedilol 59 antiandrogen 59 amlodipine 59 methotrexate MTX 59 lenalidomide dexamethasone 59 BAY #-# 59 eltrombopag 59 palifosfamide 59 Phase 2b study 59 rifapentine 59 caspofungin 59 ribavirin therapy 59 depsipeptide 59 fondaparinux 59 IMC A# 59 #mg BID [003] 59 TNFerade 59 #mg dose [003] 59 cART 59 Eli Lilly Gemzar 59 pegylated interferon alpha 2a 59 Pegintron 59 3TC lamivudine Epivir 59 Temozolomide 59 PEG Intron 59 BARACLUDE ® 59 glatiramer acetate 59 relapsed refractory multiple myeloma 59 imatinib mesylate 59 xenograft models 59 amprenavir 59 Revlimid 59 pemetrexed Alimta 59 ZOLINZA 59 metastatic castrate resistant 59 FOLFIRINOX 59 KRAS mutations occur 59 Epivir 59 ofatumumab 59 Paraplatin ® 59 temozolomide TMZ 59 glargine 59 abatacept 59 mTOR inhibitors 59 relapsed MM 59 advanced unresectable 58 nucleoside reverse transcriptase inhibitor 58 interferon gamma 1b 58 SPRYCEL 58 ganetespib 58 Phase Ib II 58 cytotoxic 58 CYT# 58 anti EGFR antibody 58 levofloxacin 58 tacrolimus ointment 58 Tavocept 58 BMS # 58 TELINTRA 58 mg/m2/day 58 LY# [003] 58 pralatrexate 58 alvespimycin 58 Telintra 58 tinidazole 58 CIMZIA ™ 58 cytarabine daunorubicin 58 regorafenib 58 cidofovir 58 IFN alfa 58 anti leukemic 58 metaglidasen 58 LMWH 58 cyclophosphamide doxorubicin vincristine 58 evaluable 58 mTOR inhibitor 58 paclitaxel cisplatin 58 peginterferon alfa 2a #KD 58 tumor shrinkage 58 HER2 + 58 REVLIMID 58 sustained virologic response 58 tenofovir DF 58 rilpivirine 58 alpha 2a 58 telaprevir dosing 58 maraviroc 58 ZACTIMA 58 nucleoside analogue 58 pegylated interferon peg IFN 58 #mg QD [002] 58 epoetin 58 efavirenz EFV 58 immunomodulatory therapy 58 rhGH 58 recurrent metastatic 58 complete cytogenetic response 58 surrogate endpoint 58 Neulasta ® 58 mg d 58 leukemia AML 58 Mylotarg 58 biologic DMARD 58 trastuzumab DM1 58 Navelbine ® 58 maximally tolerated dose 58 Nexavar ® 58 non squamous NSCLC 58 #mg BID [001] 58 Caelyx 58 lopinavir 58 alkylating agents 58 anthracyclines 58 vinca alkaloid 58 bosentan 58 risedronate 58 Neoadjuvant 58 Reolysin 58 SUTENT 58 PEGPH# 58 cisplatin carboplatin 58 PSMA ADC 58 prospectively defined 58 viral kinetic 58 metastatic CRPC 58 Cetuximab 58 #mg QD [001] 58 belinostat 58 indolent NHL 58 metastatic NSCLC 58 Erbitux cetuximab 58 immunosuppressant 58 IFN α 58 MabThera 58 BEXXAR 58 PEG interferon 58 Topotecan 58 mg/m2 dose 58 alpha interferon 58 eptifibatide 58 rFSH 58 VIRAMUNE 58 ONTAK 58 visilizumab 58 telbivudine 58 randomized 58 Pazopanib 58 citalopram 58 gastrointestinal stromal tumors 58 complete remissions 58 voriconazole 58 obatoclax 58 Tasigna 58 AEG# 58 olaparib 58 KRAS status 58 KRN# 58 CR nPR 58 bevacizumab Avastin R 58 sevelamer 58 adjuvant radiotherapy 58 MAGE A3 ASCI 58 nucleoside analogs 58 azacytidine 58 fallopian tube carcinoma 58 DMARD therapy 58 imipenem 58 lumiliximab 58 nucleoside analog 58 weekly subcutaneous injections 58 mcg dose 58 Peginterferon 58 CLL SLL 58 intravesical 58 tumor progression TTP 58 prostate cancer CRPC 58 chemoradiation therapy 58 Sunitinib 58 alemtuzumab 58 PD LID 58 rivaroxaban 58 pegylated liposomal doxorubicin PLD 58 olmesartan 58 darunavir r 58 S/GSK# 58 PEG IFN 58 chemo radiotherapy 58 IFN alpha 58 irinotecan doxorubicin oxaliplatin paclitaxel 58 Cloretazine R VNP#M 58 Phase Ib 58 q8h 58 oral chemotherapeutic agent 58 vincristine 58 darbepoetin alfa 58 folinic acid 58 entinostat 58 imatinib resistant 58 desvenlafaxine succinate 58 Asentar 58 PEGINTRON TM 58 TREANDA 58 valsartan 58 dosing schedules 58 Median survival 58 CsA 58 intravenously administered 58 Telcyta 58 Ceflatonin 58 romidepsin 58 tiotropium bromide 58 leukemia CLL 58 endocrine therapy 58 DMARDS 58 pancreatic adenocarcinoma 58 thalidomide dexamethasone 58 REOLYSIN ® 58 BRIM2 58 uric acid lowering 58 STELARA 58 HBeAg positive patients 58 PREZISTA ritonavir 58 mitoxantrone plus 58 immunotherapy 58 oxaliplatin Eloxatin 58 comparator PI r 58 metastatic colorectal carcinoma 58 metastatic renal cell 58 cyclophosphamide Cytoxan 58 biochemical relapse 58 budesonide 58 apremilast 58 ABVD 58 panitumumab Vectibix 58 disease progression 58 cell lung cancer 58 Pertuzumab 58 receptor tyrosine kinase inhibitor 58 radiochemotherapy 58 anakinra 58 xanthine oxidase inhibitor 58 FTY# 58 pregabalin 58 mg/m2 IV 58 carfilzomib 58 complete cytogenetic 58 PROVENGE 58 miconazole 58 Afinitor 58 mg RDEA# 57 oral ridaforolimus 57 VICTRELIS 57 MGCD# [001] 57 overlapping toxicities 57 #mg dose [001] 57 plus prednisone prednisolone 57 relapsed myeloma 57 Zolinza 57 COMBIVIR 57 trabedersen 57 Xanafide 57 PLX# 57 strontium ranelate 57 Platinol ® 57 steroid dexamethasone 57 Alpharadin 57 pyrazinamide 57 granisetron 57 gastrointestinal stromal tumors GIST 57 angiogenesis inhibitor 57 prior chemotherapy regimens 57 Vidaza ® 57 erlotinib Tarceva 57 evaluating REVLIMID 57 temsirolimus Torisel ® 57 imatinib mesylate Gleevec 57 metastatic disease 57 hormone refractory metastatic prostate 57 #mg/kg [002] 57 Seliciclib 57 ISTODAX 57 Zometa 57 tolvaptan 57 everolimus 57 imatinib Gleevec ® 57 disease modifying antirheumatic 57 ZYBRESTAT 57 HBeAg negative patients 57 Arixtra 57 Darunavir 57 chemotherapeutics 57 stage IIIB 57 continuous intravenous infusion 57 KRAS wild 57 XYOTAX 57 ZYVOX 57 TDF FTC 57 polymerase inhibitor 57 follicular NHL 57 oral diclofenac 57 NXL# 57 farletuzumab 57 taxotere 57 vincristine doxorubicin 57 GEMZAR 57 SCIg 57 Epirubicin 57 CLARITY study 57 androgen deprivation 57 VNP#M 57 trans retinoic acid ATRA 57 patients evaluable 57 Viread Emtriva 57 Proleukin 57 RoACTEMRA 57 Copegus 57 Alocrest 57 remission CR 57 GnRH agonist 57 ARIMIDEX 57 etanercept Enbrel 57 Gleevec imatinib 57 LIALDA 57 alefacept 57 aflibercept VEGF Trap 57 Fulvestrant 57 epoetin beta 57 unresectable stage 57 fenofibric acid 57 ascending dose 57 Darusentan 57 virologic 57 Elotuzumab 57 Median progression 57 solid tumors 57 Paraplatin ® carboplatin 57 Epivir HBV 57 immunomodulator 57 serum phosphorus 57 atypical antipsychotic 57 lixisenatide 57 stavudine 57 PKC# 57 pegylated 57 lymphoma CTCL 57 rindopepimut 57 stavudine d4T